246 related articles for article (PubMed ID: 9668674)
1. Noradrenergic modulation of methamphetamine-induced striatal dopamine depletion.
Fornai F; Alessandrì MG; Torracca MT; Bassi L; Scalori V; Corsini GU
Ann N Y Acad Sci; 1998 May; 844():166-77. PubMed ID: 9668674
[TBL] [Abstract][Full Text] [Related]
2. Noradrenergic Modulation of Methamphetamine-Induced Striatal Dopamine Depletion.
Fornai F; Alessandrì MG; Torrac MT; Bassi L; Scalori V; Corsini GU
Ann N Y Acad Sci; 1998 May; 844(1):166-177. PubMed ID: 29090815
[TBL] [Abstract][Full Text] [Related]
3. Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions.
Fornai F; Alessandrì MG; Torracca MT; Bassi L; Corsini GU
J Pharmacol Exp Ther; 1997 Oct; 283(1):100-7. PubMed ID: 9336313
[TBL] [Abstract][Full Text] [Related]
4. Norepinephrine loss selectively enhances chronic nigrostriatal dopamine depletion in mice and rats.
Fornai F; Torracca MT; Bassi L; D'Errigo DA; Scalori V; Corsini GU
Brain Res; 1996 Oct; 735(2):349-53. PubMed ID: 8911678
[TBL] [Abstract][Full Text] [Related]
5. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
Srinivasan J; Schmidt WJ
Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435
[TBL] [Abstract][Full Text] [Related]
6. Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice.
Fornai F; Bassi L; Torracca MT; Scalori V; Corsini GU
Eur J Pharmacol; 1995 Sep; 283(1-3):99-102. PubMed ID: 7498327
[TBL] [Abstract][Full Text] [Related]
7. Restoration of ascending noradrenergic projections by residual locus coeruleus neurons: compensatory response to neurotoxin-induced cell death in the adult rat brain.
Fritschy JM; Grzanna R
J Comp Neurol; 1992 Jul; 321(3):421-41. PubMed ID: 1506478
[TBL] [Abstract][Full Text] [Related]
8. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex.
Devoto P; Flore G; Pani L; Gessa GL
Mol Psychiatry; 2001 Nov; 6(6):657-64. PubMed ID: 11673793
[TBL] [Abstract][Full Text] [Related]
9. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents.
Albers DS; Sonsalla PK
J Pharmacol Exp Ther; 1995 Dec; 275(3):1104-14. PubMed ID: 8531070
[TBL] [Abstract][Full Text] [Related]
10. Further studies of the role of hyperthermia in methamphetamine neurotoxicity.
Bowyer JF; Davies DL; Schmued L; Broening HW; Newport GD; Slikker W; Holson RR
J Pharmacol Exp Ther; 1994 Mar; 268(3):1571-80. PubMed ID: 8138969
[TBL] [Abstract][Full Text] [Related]
11. Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex.
Devoto P; Flore G; Longu G; Pira L; Gessa GL
Synapse; 2003 Dec; 50(3):200-5. PubMed ID: 14515337
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration.
Pérez V; Sosti V; Rubio A; Barbanoj M; Rodríguez-Alvarez J; Kulisevsky J
Eur J Pharmacol; 2007 Dec; 576(1-3):83-90. PubMed ID: 17888901
[TBL] [Abstract][Full Text] [Related]
13. Effects of pretreatment with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) on methamphetamine pharmacokinetics and striatal dopamine losses.
Fornai F; Giorgi FS; Alessandrì MG; Giusiani M; Corsini GU
J Neurochem; 1999 Feb; 72(2):777-84. PubMed ID: 9930753
[TBL] [Abstract][Full Text] [Related]
14. Amphetamines induce ubiquitin-positive inclusions within striatal cells.
Fornai F; Lazzeri G; Lenzi P; Gesi M; Ferrucci M; Soldani P; Pellegrini A; Capobianco L; De Blasi A; Ruggieri S; Paparelli A
Neurol Sci; 2003 Oct; 24(3):182-3. PubMed ID: 14598077
[TBL] [Abstract][Full Text] [Related]
15. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen.
Pereira FC; Lourenço ES; Borges F; Morgadinho T; Ribeiro CF; Macedo TR; Ali SF
Synapse; 2006 Sep; 60(3):185-93. PubMed ID: 16739116
[TBL] [Abstract][Full Text] [Related]
16. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum.
Bowyer JF; Tank AW; Newport GD; Slikker W; Ali SF; Holson RR
J Pharmacol Exp Ther; 1992 Feb; 260(2):817-24. PubMed ID: 1346646
[TBL] [Abstract][Full Text] [Related]
17. Effects of low dose N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine administration on exploratory and amphetamine-induced behavior and dopamine D2 receptor function in rats with high or low exploratory activity.
Alttoa A; Kõiv K; Eller M; Uustare A; Rinken A; Harro J
Neuroscience; 2005; 132(4):979-90. PubMed ID: 15857703
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms involved in the formation of dopamine-induced intracellular bodies within striatal neurons.
Lazzeri G; Lenzi P; Busceti CL; Ferrucci M; Falleni A; Bruno V; Paparelli A; Fornai F
J Neurochem; 2007 Jun; 101(5):1414-27. PubMed ID: 17286589
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen increases methamphetamine-evoked dopamine output from superfused striatal tissue fragments of male mice.
Willett MC; Dluzen DE
Brain Res; 2004 Dec; 1029(2):186-94. PubMed ID: 15542073
[TBL] [Abstract][Full Text] [Related]
20. Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex.
Pan WH; Yang SY; Lin SK
Synapse; 2004 Jul; 53(1):44-52. PubMed ID: 15150740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
